相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA damage-induced apoptosis and mitogen-activated protein kinase pathway contribute to the toxicity of dronedarone in hepatic cells
Si Chen et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2018)
Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans
Dianke Yu et al.
ARCHIVES OF TOXICOLOGY (2018)
Current limitations and future opportunities for prediction of DILI from in vitro
Christoph Funk et al.
ARCHIVES OF TOXICOLOGY (2017)
Novel Pathways of Ponatinib Disposition Catalyzed By CYP1A1 Involving Generation of Potentially Toxic Metabolites
De Lin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Development and Application of a Dual Rat and Human AHR Activation Assay
Martin R. Brown et al.
TOXICOLOGICAL SCIENCES (2017)
Comparison of xenobiotic-metabolising human, porcine, rodent, and piscine cytochrome P450
Viktoriia Burkina et al.
TOXICOLOGY (2017)
Gene co-expression network analysis identifies porcine genes associated with variation in metabolizing fenbendazole and flunixin meglumine in the liver
Jeremy T. Howard et al.
SCIENTIFIC REPORTS (2017)
MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation
Linjuan Zeng et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments
Richard A. Thompson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2016)
Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity
Jiekun Xuan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells
Zhen Ren et al.
TOXICOLOGICAL SCIENCES (2016)
The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity
Qiangen Wu et al.
TOXICOLOGY LETTERS (2016)
Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone
Yanjun Hong et al.
MOLECULAR PHARMACOLOGY (2016)
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment
Igor Koturbash et al.
BIOMARKERS IN MEDICINE (2015)
Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine
Zhi-Xu He et al.
DRUG METABOLISM REVIEWS (2015)
Polycyclic Aromatic Hydrocarbons: From Metabolism to Lung Cancer
Bhagavatula Moorthy et al.
TOXICOLOGICAL SCIENCES (2015)
Ginkgo biloba leaf extract induces DNA damage by inhibiting topoisomerase II activity in human hepatic cells
Zhuhong Zhang et al.
SCIENTIFIC REPORTS (2015)
Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance
A. N. Werk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Hepatic toxicity of dronedarone in mice: Role of mitochondrial β-oxidation
Andrea Felser et al.
TOXICOLOGY (2014)
Sertraline induces endoplasmic reticulum stress in hepatic cells
Si Chen et al.
TOXICOLOGY (2014)
Trovafloxacin Enhances Lipopolysaccharide-Stimulated Production of Tumor Necrosis Factor-α by Macrophages: Role of the DNA Damage Response
Kyle L. Poulsen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug
Sylvie Klieber et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters
Lun Yang et al.
PLOS ONE (2013)
Mechanisms of Hepatocellular Toxicity Associated with Dronedarone-A Comparison to Amiodarone
Andrea Felser et al.
TOXICOLOGICAL SCIENCES (2013)
Mechanism study of goldenseal-associated DNA damage
Si Chen et al.
TOXICOLOGY LETTERS (2013)
Drug safety evaluation of dronedarone in atrial fibrillation
Gaetano M. De Ferrari et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent
Yan Li et al.
TOXICOLOGICAL SCIENCES (2012)
Similarities and Differences in the Expression of Drug-Metabolizing Enzymes between Human Hepatic Cell Lines and Primary Human Hepatocytes
Lei Guo et al.
DRUG METABOLISM AND DISPOSITION (2011)
Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration
Gaetano Serviddio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Dronedarone in High-Risk Permanent Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Methysticin and 7,8-Dihydromethysticin are Two Major Kavalactones in Kava Extract to Induce CYP1A1
Yan Li et al.
TOXICOLOGICAL SCIENCES (2011)
Update Information on Drug Metabolism Systems-2009, Part II. Summary of Information on the Effects of Diseases and Environmental Factors on Human Cytochrome P450 (CYP) Enzymes and Transporters
Slobodan Rendic et al.
CURRENT DRUG METABOLISM (2010)
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver
Xia Yang et al.
GENOME RESEARCH (2010)
Clinical Pharmacology of Dronedarone: Implications for the Therapy of Atrial Fibrillation
Paul Dorian
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Gene Expression Profiling as an Initial Approach for Mechanistic Studies of Toxicity and Tumorigenicity of Herbal Plants and Herbal Dietary Supplements
Lei Guo et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2010)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract
Lei Guo et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
David J. Waxman et al.
MOLECULAR PHARMACOLOGY (2009)
Sex-specific differences in CYP450 isoforms in humans
Marissa J. Scandlyn et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Increased mortality after dronedarone therapy for severe heart failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo
B. J. Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
CYP1A induction and human risk assessment: An evolving tale of in vitro and in vivo studies
Qiang Ma et al.
DRUG METABOLISM AND DISPOSITION (2007)
Induction of Cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: Results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro
Wenyue Hu et al.
MOLECULAR PHARMACOLOGY (2007)
The human hepatoma HepaRG cells: A highly differentiated model for studies of liver metabolism and toxicity of xenobiotics
Andre Guillouzo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2007)
Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity
A Westlind-Johnsson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons
Tsutomu Shimada
DRUG METABOLISM AND PHARMACOKINETICS (2006)
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450IA2, 2D6, 2E1, and 3A4/5 phenotypes
BJ Gurley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
The influence of age and sex on the clearance of cytochrome P450 3A substrates
MM Cotreau et al.
CLINICAL PHARMACOKINETICS (2005)
Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups
SJ Lee et al.
PHARMACOGENETICS (2003)
Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: Comparison with grapefruit juice
DG Bailey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Dietary effects on drug metabolism and transport
RZ Harris et al.
CLINICAL PHARMACOKINETICS (2003)
The genetic determinants of the CYP3A5 polymorphism
E Hustert et al.
PHARMACOGENETICS (2001)
分享论文
